UHS: Symmetrical Triangle detected on 9 Jul 2026

UHS is forming a symmetrical triangle pattern with structure scoring 14/15, indicating well-defined converging support and resistance levels. Current price of $156.43 sits near the upper bound of the consolidation, bracketed by key resistance at $146.76 and support at $140.55. The breakout score of 11/13 and volume score of 11/12 suggest moderate-to-decent conditions for a directional move. Volume ratio of 1.28x average indicates above-normal interest. The pattern quality score of 36/40 reflects solid technical setup amid 67.26% win probability. Price is down 36.29% from the 52-week high but up 11.67% from the 52-week low, positioning the stock in a recovery context within a broader consolidation.

UHS reported net income of $5.65 per diluted share in Q1 2026, up from $4.80 in Q1 2025, with net revenues increasing 9.6% to $4.495 billion in Q1 2026 versus $4.100 billion in Q1 2025. The acquisition of Talkspace adds virtual behavioral health services to UHS's portfolio, expanding the company's service mix. UHS guides for 2026 revenue, EBITDA, and EPS growth of 7%, 5%, and 9% at the midpoint. The healthcare sector environment is bullish (regime score 0.92), and Q2 2026 earnings are scheduled for release after market close July 27, just 18 days away—a near-term catalyst that could either validate or disrupt this consolidation.

A successful breakout above the triangle resistance would target $163.52 (measured move based on the conservative target). Volume confirmation is critical given the moderate volume backdrop; sustained turnover above the 1.28x current ratio strengthens conviction. The invalidation level sits at support of $140.55—a close below this price would signal pattern failure and likely trigger reversal. With 67.26% historical win probability for this pattern type and a bullish sector regime (0.92), the odds favor upside, though the upcoming earnings event (July 27) introduces binary risk. Price action into this date will be key to pattern development.

Key risks include ACA subsidy expirations and Medicaid reimbursement cuts. Q2 2026 earnings release on July 27 with investor call July 28 represents a major near-term catalyst just 18 days away—disappointments on revenue or margin guidance could spark sharp downside. RSI at 57.26 shows neutral momentum with no overbought extremes, but beta of 0.31 indicates relatively low volatility sensitivity that could mask sudden moves around earnings. Analysts recently reduced price targets by approximately $24 on balance due to weaker Q4 acute care results. While short interest appears relatively low, the combination of recent analyst downgrades and imminent earnings creates execution risk that could invalidate the triangle setup if results disappoint.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.